Print

Aerocrine Signs Distribution Agreement With Third Largest Chinese Pharmaceutical Company  
9/25/2012 10:09:42 AM

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) today announces the signing of an import and distribution agreement with Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) for Aerocrine’s products for the Chinese market. SPH is the third largest pharmaceutical company in China, with an extensive network of local sales people across China.